HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip Bonomi Selected Research

Autoantibodies

1/2021Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition.
7/2011Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers.
7/2010Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip Bonomi Research Topics

Disease

46Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 02/2002
31Neoplasms (Cancer)
08/2021 - 02/2002
13Lung Neoplasms (Lung Cancer)
10/2019 - 02/2002
10Disease Progression
06/2016 - 11/2006
5Adenocarcinoma of Lung
12/2014 - 07/2010
3Weight Gain
10/2019 - 11/2011
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2018 - 02/2002
2Fibrosis (Cirrhosis)
01/2018 - 09/2005
2Thrombocytopenia (Thrombopenia)
06/2016 - 03/2011
2Adenocarcinoma
01/2014 - 10/2012
2Lymphatic Metastasis
07/2011 - 03/2009
2Neoplasm Metastasis (Metastasis)
07/2009 - 02/2002
1Cardiovascular Diseases (Cardiovascular Disease)
08/2021
1Atrial Fibrillation
08/2021
1Sinus Tachycardia
08/2021
1Pulmonary Embolism
08/2021
1Left Ventricular Dysfunction
08/2021
1Renal Cell Carcinoma (Grawitz Tumor)
01/2020
1Cachexia
10/2019
1Anorexia
10/2019
1Inflammation (Inflammations)
01/2018
1Circulating Neoplastic Cells
01/2018
1Neutropenia
06/2016
1Pathologic Complete Response
10/2015
1Fatigue
02/2015
1Peptic Ulcer (Peptic Ulcers)
04/2008
1Gastrointestinal Hemorrhage (Hematochezia)
04/2008

Drug/Important Bio-Agent (IBA)

11Biomarkers (Surrogate Marker)IBA
01/2021 - 08/2004
6Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018 - 08/2003
6Pemetrexed (MTA)FDA Link
05/2015 - 07/2006
6Paclitaxel (Taxol)FDA LinkGeneric
05/2015 - 05/2006
5Carboplatin (JM8)FDA LinkGeneric
05/2015 - 08/2007
5PlatinumIBA
03/2015 - 02/2002
4Gefitinib (Iressa)FDA Link
01/2018 - 08/2003
4Bevacizumab (Avastin)FDA Link
05/2015 - 07/2009
4Proteins (Proteins, Gene)FDA Link
07/2013 - 03/2011
3AutoantibodiesIBA
01/2021 - 07/2010
3Cisplatin (Platino)FDA LinkGeneric
06/2016 - 02/2002
3ParaffinIBA
01/2014 - 05/2007
3ErbB Receptors (EGF Receptor)IBA
01/2014 - 08/2003
3Cytotoxins (Cytolysins)IBA
04/2007 - 08/2003
2Immune Checkpoint InhibitorsIBA
01/2021 - 01/2020
2AutoantigensIBA
01/2021 - 07/2011
2Monoclonal AntibodiesIBA
10/2019 - 07/2008
2GemcitabineFDA Link
06/2016 - 07/2006
2Formaldehyde (Formol)FDA Link
01/2014 - 12/2012
2Insulin-Like PeptidesIBA
05/2012 - 11/2011
2Tyrosine Kinase InhibitorsIBA
05/2007 - 08/2003
2paclitaxel poliglumex (XYOTAX)IBA
04/2007 - 05/2006
1Dihydrotachysterol (AT 10)IBA
08/2021
1Adenosine (Adenocard)FDA LinkGeneric
01/2020
1GhrelinIBA
10/2019
1Ado-Trastuzumab EmtansineIBA
01/2019
1Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2018
1B7-H1 AntigenIBA
01/2018
1pembrolizumabIBA
01/2018
1necitumumabIBA
06/2016
1RamucirumabIBA
03/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2015
1Transcription Factors (Transcription Factor)IBA
01/2014
1src-Family KinasesIBA
07/2013
1LipidsIBA
07/2013
1Epidermal Growth Factor (EGF)IBA
07/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2013
1Heat-Shock Proteins (Heat-Shock Protein)IBA
06/2013
1STA 9090IBA
06/2013
1EC145IBA
10/2012
1Folic Acid (Vitamin M)FDA LinkGeneric
10/2012
1Somatomedin Receptors (Somatomedin Receptor)IBA
03/2012
1C-PeptideIBA
11/2011
1Insulin-Like Growth Factor I (IGF-1)IBA
11/2011
1Insulin-Like Growth Factor Binding ProteinsIBA
11/2011
1navitoclaxIBA
03/2011
1big gastrinIBA
03/2011
1Peptides (Polypeptides)IBA
03/2011
1Xanthine DehydrogenaseIBA
02/2011
1AlbuminsIBA
07/2009
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
07/2009
1denileukin diftitox (Ontak)FDA Link
06/2009
1mapatumumabIBA
07/2008
1Celecoxib (Celebrex)FDA Link
04/2008
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
04/2008
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2008
1ixabepilone (BMS 247550)FDA Link
08/2007
1epothilone B (EPO906)IBA
08/2007
1taxaneIBA
08/2007
1Taxoids (Taxanes)IBA
04/2007
1Docetaxel (Taxotere)FDA Link
04/2007
1PolymersIBA
04/2007

Therapy/Procedure

23Therapeutics
01/2020 - 02/2002
16Drug Therapy (Chemotherapy)
01/2021 - 02/2002
5Chemoradiotherapy
12/2015 - 06/2011
3Immunotherapy
01/2021 - 10/2019
3Radiotherapy
09/2014 - 09/2005
2Neoadjuvant Therapy
10/2013 - 07/2011
1Ambulatory Care (Outpatient Care)
08/2021
1Precision Medicine
08/2017
1Intravenous Infusions
06/2013
1Pneumonectomy (Lung Volume Reduction)
09/2009
1Combination Drug Therapy (Combination Chemotherapy)
07/2009